NCT01500642View on ClinicalTrials.gov

Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Pollen Allergy
Interventions
BIOLOGICAL

Slit One

slit one sublingual immunotherapy 200 stu

BIOLOGICAL

Slit One

slit one vestibular immunotherapy 200 stu

BIOLOGICAL

Slit One ragweed

slit one 400 stu dose ragweed (sublingual doubled immunotherapy)

Trial Locations (1)

20157

Luigi Sacco Hospital, Milan

All Listed Sponsors
collaborator

ALK-Abelló A/S

INDUSTRY

lead

ASST Fatebenefratelli Sacco

OTHER

NCT01500642 - Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy | Biotech Hunter | Biotech Hunter